Human erythrocyte-derived nanovesicles can readily be loaded with doxorubicin and act as anticancer agents.

Purpose: In future therapeutics new formulas are needed that assure lower doses, fewer side effects, targeted administration and protection of the drug from degradation. In a first step to fulfil t ...